RETIRED: The role of adjuvant therapy in endometrial cancer

Rachel Kupets; Tien Le; SOGC-GOC-SCC POLICY AND PRACTICE GUIDELINES COMMITTEE; SPECIAL CONTRIBUTORS

doi:10.1016/S1701-2163(15)30968-3

RETIRED: The role of adjuvant therapy in endometrial cancer

J Obstet Gynaecol Can. 2013 Apr;35(4):375-376. doi: 10.1016/S1701-2163(15)30968-3.

[Article in English, French]

Authors

Rachel Kupets¹, Tien Le²; SOGC-GOC-SCC POLICY AND PRACTICE GUIDELINES COMMITTEE; SPECIAL CONTRIBUTORS

Collaborators

Tien Le², James Bentley³, Scott Farrell³, Michel P Fortier⁴, Christopher Giede⁵, Rachel Kupets¹, Marie Plante⁴, Patti Power⁶, Marie-Claude Renaud⁴, Alexandra Schepansky⁷, Vyta Senikas², Janice Kwon⁸, Michel Préfontaine⁹, Isabelle Germain⁴, Robert Pearcey⁷, David D'Souza⁹, Mary Senterman², Paul Hoskins⁸

Affiliations

¹ Toronto ON.
² Ottawa ON.
³ Halifax NS.
⁴ Quebec QC.
⁵ Saskatoon SK.
⁶ St. John's NL.
⁷ Edmonton AB.
⁸ Vancouver BC.
⁹ London ON.

PMID: 23660048
DOI: 10.1016/S1701-2163(15)30968-3

Abstract

This document has been archived because it contains outdated information. It should not be consulted for clinical use, but for historical research only. Please visit the journal website for the most recent guidelines.

Keywords: chemotherapy; endometrial cancer; radiation therapy.

Publication types

Practice Guideline

MeSH terms

Brachytherapy
Chemotherapy, Adjuvant*
Endometrial Neoplasms / pathology
Endometrial Neoplasms / surgery*
Endometrial Neoplasms / therapy
Female
Humans
Neoplasm Staging
Radiotherapy, Adjuvant*
Risk Assessment